glp-1 and type 1 diabetes Is the Same as Ozempic? Understanding Key Differences GLP-1-based therapies for type 2
Description
Mezquita Raya, M
They act as a bridgenot a crutchto sustainable change
A total of 225 participants were included in the modified intention-to-treat population and assigned to tirzepatide 10 mg ( n = 73), 15 mg ( n = 77), or placebo ( n = 75), alongside lifestyle modifications
Copyright 2026 by the American Physiological Society
